Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy

saladax

Saladax is very excited to share a press release that went out last week. The title of the press release is “Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy.”

The link to the press release is www.businesswire.com

This press release marks a major milestone in therapeutic drug monitoring (TDM) of chemotherapeutic drugs. Not having guidelines have been a barrier to oncologists for broad adoption. The IATDMCT guidelines will give oncologist a greater comfort level in dosing patients according to TDM verses traditional body surface area.